MedAssets Inc. Reaches New 12-Month High at $24.44 (MDAS)
MedAssets (NASDAQ:MDAS)’s share price reached a new 52-week high on Tuesday, Analyst Ratings.Net reports. The company traded as high as $24.44 and last traded at $24.24, with a volume of 369,639 shares traded. The stock had previously closed at $23.78.
Several analysts have recently commented on the stock. Analysts at Zacks downgraded shares of MedAssets (NASDAQ:MDAS) from an “outperform” rating to a “neutral” rating in a research note to investors on Monday, August 19th. They now have a $25.80 price target on the stock. Separately, analysts at KeyCorp initiated coverage on shares of MedAssets (NASDAQ:MDAS) in a research note to investors on Tuesday, August 13th. They set a “hold” rating on the stock. Finally, analysts at Raymond James raised their price target on shares of MedAssets (NASDAQ:MDAS) from $22.00 to $27.00 in a research note to investors on Tuesday, August 6th. They now have a “strong-buy” rating on the stock.
Three investment analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $25.76.
In other MedAssets news, Director Harris Iv Hyman sold 3,199 shares of MedAssets stock in a transaction dated Thursday, August 29th. The stock was sold at an average price of $23.26, for a total value of $74,408.74. Following the completion of the sale, the director now directly owns 4,652 shares in the company. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
MedAssets has a 52 week low of $15.40 and a 52 week high of $24.17. The stock’s 50-day moving average is $22.79 and its 200-day moving average is $19.47. The company has a market cap of $1.485 billion and a price-to-earnings ratio of 354.93.
MedAssets (NASDAQ:MDAS) last posted its quarterly earnings results on Wednesday, July 31st. The company reported $0.30 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.26 by $0.04. The company had revenue of $170.70 million for the quarter, compared to the consensus estimate of $167.64 million. During the same quarter in the prior year, the company posted $0.28 earnings per share. The company’s quarterly revenue was up 4.7% on a year-over-year basis. On average, analysts predict that MedAssets will post $1.31 earnings per share for the current fiscal year.
MedAssets, Inc (NASDAQ:MDAS) provides technology-enabled products and services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.